IL15 and neoplasm: Similarly, in lung cancer models, GD2-specific CAR-T cells expressing IL-15 and incorporating an inducible caspase-9 (iC9) safety switch demonstrated sustained persistence and robust antitumor activity, consistent with findings in other GD2-expressing tumor models (47).